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Lymphatic vessels are traditionally considered as trans-
porters of fluid, solutes, lipids, and cells from peripheral
tissues to lymph nodes and back to the blood circulation,
and their dysfunction can lead to lymphedema. However, a
renaissance of lymphatic research in the last decade has not
only deepened our understanding of the molecular and
biomechanical mechanisms underlying lymphatic devel-
opment and function, but has also enabled us to appreciate
the scope of influence that lymphatic vessels wield in many
other physiological and pathophysiological processes
including metabolism, inflammation, immunity, and tissue
repair and remodeling, among others. The potential roles of
lymphatic vessels in metabolism continues to intrigue as an
increasing number of collaborations have been revealed
between lymphatic vessels and adipocytes, and the cross-
talk between lymphatic endothelial cells and other stromal
cells (particularly in lymph stasis and fibrosis) is being
revealed. The importance of biomechanical forces in
lymphatic development and function are being discovered.
Questions in the field abound and tools to address them are
rapidly becoming available. Areas ripe for exploration span
multiple disciplines and include understanding how dif-
ferent organs control the development of their respective
lymphatic vasculatures, how lymphatic endothelial cells
sense and modulate their biochemical environment, how
lymphatic vessels contribute to metabolism, and the func-
tional consequences of adult lymphangiogenesis.
Whereas most these areas of focus remain largely
unexplored, recent progress has been exceptionally rich in
the area of how the lymphatic vasculature influences
inflammation and immunity. Tumor-associated lym-
phangiogenesis has long been correlated with tumor
progression and metastasis, but we now know that lym-
phangiogenesis is also associated with nearly all acute
and chronic inflammatory processes, both locally and in
the draining lymph node. Furthermore, the last few years
have brought to light completely new roles for both
lymphatic endothelial cells and their drainage functions in
directly modulating adaptive immunity, for example by
modulating dendritic cell maturation as well as by
directly presenting antigens to T cells to regulate their
differentiation programs. Questions in the field include
whether lymphangiogenesis negatively or positively
affects the development of chronic inflammatory diseases,
the resolution of acute inflammation, the rejection of
transplanted organs, and the regulation of tumor immu-
nity and autoimmune diseases.
This special issue of Angiogenesis aims to highlight the
exciting new research focused on lymphangiogenesis in
inflammation. Five review articles (ref von der Wied,
Detmar, Johnson, Angeli and Halin) give different per-
spectives of the roles of lymphatic vessels and lymphan-
giogenesis in inflammation. Lymphangiogenesis in chronic
inflammation and cancer is the subject of reviews by Liao
and von der Weid (10.1007/s10456-014-9416-7), Dieterich
et al. (10.1007/s10456-013-9406-1), and Tan et al. (10.
1007/s10456-014-9419-4). Aebischer et al. focuses on the
response of lymphatic endothelial cells to inflammatory
cues (10.1007/s10456-013-9404-3), while Johnson and
Jackson discuss the regulation of dendritic cell trafficking
into lymphatic vessels by the lymphatic endothelium (10.
1007/s10456-013-9407-0).
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This series of review articles is followed by four original
research articles exploring lymphatic endothelial cell
(LEC) response to inflammatory mediators as well as
radiation and photodynamic therapy (PDT)-induced dam-
age. Cromer et al. (10.1007/s10456-013-9393-2) explores
the barrier function of the lymphatic endothelium to bac-
terial lipopolysaccharide (LPS) as well as inflammatory
cytokines and demonstrates that while all tested mediators
decrease the LEC barrier function, IFN-c does so much
more than the others. They also show these increases in
permeability are dependent on nitric oxide signaling and
correlated with changes in VE-cadherin as well as cyto-
skeletal activation. Hsu et al. (10.1007/s10456-013-9386-1)
explores mechanisms of how IL-6, which is upregulated in
many cancers, can induce lymphangiogenesis. Specifically,
they report evidence supporting a mechanism whereby IL-
6 activates ERK1/2 and p38MAPK in a Src-dependent
manner, which in turn results in C/EBPb and p65 binding
to the VEGF-C promoter, driving its expression. In this
way, IL-6 directly leads to VEGF-C activation and
lymphangiogenesis.
Kilarski et al. (10.1007/s10456-013-9365-6) examines
the use of PDT for lymphatic-specific ablation, whereby
photosensitizer is taken up by dermal lymphatic vessels
after being injected intradermally and irradiated to destroy
lymphatic vessels locally. They determined the dosage
effects of both light and photosensitizer on the degree to
which lymphatic vessels can be selectively destroyed with
minimal damage to blood vessels and interstitial tissue.
They also explore mechanisms of lymphatic occlusion and
regeneration, demonstrating vessel regeneration by LEC
repopulation of previous vessel ‘ghosts’. Finally, Kesler
et al. (10.1007/s10456-013-9400-7) address the question of
why some breast cancer patients develop lymphedema after
radiation therapy, and present an interesting in vitro study
of LEC sensitivity to ionizing radiation. They report that
VEGF-C increases the radiosensitivity of LECs by
increasing the fraction of LECs in S and G2/M phases, thus
increasing DNA damage and driving LEC quiescence and
probable dysfunction. This could suggest that patients with
pre-existing inflammation, where VEGF-C is upregulated,
could predispose them to radiation-induced lymphedema.
We believe these exciting original and review articles
highlight the rapidly growing area in angiogenesis research
of lymphangiogenesis in inflammation. We hope you enjoy
this special issue.
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